Legalize59765 laws
59765 laws
- § 364e. Labeling
- § 364f. Records
- § 364g. Mandatory recall authority
- § 364h. Small businesses
- § 364i. Exemption for certain products and facilities
- § 364j. Preemption
- § 371. Regulations and hearings
- § 372. Examinations and investigations
- § 372a. Transferred
- § 373. Records
- § 374. Inspection
- § 374a. Inspections relating to food allergens
- § 375. Publicity
- § 376. Examination of sea food on request of packer; marking food with results; fees; penalties
- § 377. Revision of United States Pharmacopoeia; development of analysis and mechanical and physical tests
- § 378. Advertising of foods
- § 379dd. Establishment and functions of the Foundation
- § 379dd–1. Location of Foundation
- § 379dd–2. Activities of the Food and Drug Administration
- § 379d–1. Conflicts of interest
- § 379d–2. Policy on the review and clearance of scientific articles published by FDA employees
- § 379d–3. Streamlined hiring authority
- § 379d–3a. Hiring authority for scientific, technical, and professional personnel
- § 379d–3b. Strategic Workforce Plan and report
- § 379d–4. Reporting requirements
- § 379d–5. Guidance document regarding product promotion using the Internet
- § 379e. Listing and certification of color additives for foods, drugs, devices, and cosmetics
- § 379f. Recovery and retention of fees for freedom of information requests
- § 379g. Definitions
- § 379h. Authority to assess and use drug fees
- § 379h–1. Fees relating to advisory review of prescription-drug television advertising
- § 379h–2. Reauthorization; reporting requirements
- § 379i. Definitions
- § 379j. Authority to assess and use device fees
- § 2101. Effective date
- § 379j–1. Reauthorization; reporting requirements
- § 379j–11. Definitions
- § 379j–12. Authority to assess and use animal drug fees
- § 379j–13. Reauthorization; reporting requirements
- § 379j–21. Authority to assess and use generic new animal drug fees
- § 379j–22. Reauthorization; reporting requirements
- § 379j–31. Authority to collect and use fees
- § 379j–41. Definitions
- § 10004. Support for development programs
- § 379j–42. Authority to assess and use human generic drug fees
- § 379j–43. Reauthorization; reporting requirements
- § 379j–51. Definitions
- § 379j–52. Authority to assess and use biosimilar biological product fees
- § 379j–53. Reauthorization; reporting requirements
- § 379j–61. Definitions